Select Medical Appoints Thomas P. Mullin as New CEO, Announces Executive Leadership Changes.
PorAinvest
martes, 2 de septiembre de 2025, 5:45 pm ET1 min de lectura
SEM--
The leadership transition comes as part of a broader restructuring, with John A. Saich appointed as sole President, John F. Duggan as Executive Vice President, General Counsel and Secretary, and Michael E. Tarvin transitioning to Senior Executive Vice President of Legal Services. These appointments reflect Select Medical's commitment to fostering growth and innovation within its leadership team.
The appointment of Mullin, who has held various executive leadership roles within the company, signifies a continuity in leadership while introducing new perspectives. Chernow, who has been with the company since 2002, has been instrumental in the company's growth and will now focus on strategic initiatives as Vice Chairman.
Select Medical's operations span 40 states and the District of Columbia, with a focus on critical illness recovery, rehabilitation hospitals, and outpatient clinics. The company's revenue outlook for 2025 remains at $5.3B to $5.5B, reflecting its commitment to expanding its inpatient rehabilitation services nationwide.
The new leadership team will be crucial in navigating the evolving regulatory environment and ensuring the company's continued success in providing high-quality post-acute care services.
References:
[1] https://seekingalpha.com/news/4491479-select-medical-names-new-ceo-announces-executive-leadership-changes
[2] https://www.prnewswire.com/news-releases/select-medical-holdings-corporation-appoints-thomas-p-mullin-as-chief-executive-officer-and-announces-other-changes-involving-long-tenured-leaders-302542724.html
Select Medical Holdings has appointed Thomas P. Mullin as CEO, effective immediately. Mullin succeeds David S. Chernow, who becomes Vice Chairman of the board after serving as CEO since 2014. Mullin is a 17-year company veteran and most recently held the position of President and Chief Operating Officer.
Select Medical Holdings (NYSE: SEM) has announced significant executive changes with the appointment of Thomas P. Mullin as CEO, effective immediately. Mullin succeeds David S. Chernow, who has been promoted to Vice Chairman of the board. Mullin has been a 17-year veteran of the company and most recently served as co-president overseeing 140 hospitals in the company’s critical illness recovery and inpatient rehabilitation divisions.The leadership transition comes as part of a broader restructuring, with John A. Saich appointed as sole President, John F. Duggan as Executive Vice President, General Counsel and Secretary, and Michael E. Tarvin transitioning to Senior Executive Vice President of Legal Services. These appointments reflect Select Medical's commitment to fostering growth and innovation within its leadership team.
The appointment of Mullin, who has held various executive leadership roles within the company, signifies a continuity in leadership while introducing new perspectives. Chernow, who has been with the company since 2002, has been instrumental in the company's growth and will now focus on strategic initiatives as Vice Chairman.
Select Medical's operations span 40 states and the District of Columbia, with a focus on critical illness recovery, rehabilitation hospitals, and outpatient clinics. The company's revenue outlook for 2025 remains at $5.3B to $5.5B, reflecting its commitment to expanding its inpatient rehabilitation services nationwide.
The new leadership team will be crucial in navigating the evolving regulatory environment and ensuring the company's continued success in providing high-quality post-acute care services.
References:
[1] https://seekingalpha.com/news/4491479-select-medical-names-new-ceo-announces-executive-leadership-changes
[2] https://www.prnewswire.com/news-releases/select-medical-holdings-corporation-appoints-thomas-p-mullin-as-chief-executive-officer-and-announces-other-changes-involving-long-tenured-leaders-302542724.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema



Comentarios
Aún no hay comentarios